Compare MIDD & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MIDD | CYTK |
|---|---|---|
| Founded | 1888 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 7.6B |
| IPO Year | 1995 | 2004 |
| Metric | MIDD | CYTK |
|---|---|---|
| Price | $141.69 | $60.87 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 19 |
| Target Price | ★ $180.13 | $89.26 |
| AVG Volume (30 Days) | 503.8K | ★ 1.4M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,201,202,000.00 | $13,368,000.00 |
| Revenue This Year | $5.87 | $7.37 |
| Revenue Next Year | $3.22 | $310.19 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $110.82 | $29.31 |
| 52 Week High | $169.44 | $70.98 |
| Indicator | MIDD | CYTK |
|---|---|---|
| Relative Strength Index (RSI) | 48.85 | 36.53 |
| Support Level | $138.51 | $59.12 |
| Resistance Level | $145.77 | $64.22 |
| Average True Range (ATR) | 4.39 | 2.19 |
| MACD | 0.60 | -0.57 |
| Stochastic Oscillator | 46.11 | 1.26 |
The Middleby Corp is engaged in designing, manufacturing, marketing, distribution and service of a broad line of foodservice equipment used in all types of commercial restaurants and institutional kitchens, food preparation, cooking, baking, chilling and packaging equipment for food processing operations, and premium kitchen equipment including ranges, ovens, refrigerators, ventilation, dishwashers and outdoor cooking equipment used in the residential market. The company conducts its business through three principal business segments namely the Commercial Foodservice Equipment Group, the Food Processing Equipment Group and the Residential Kitchen Equipment Group. The firm derives majority revenue from Commercial Foodservice Equipment Group segment.
Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary diseases. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.